199 related articles for article (PubMed ID: 37239464)
1. EDLM: Ensemble Deep Learning Model to Detect Mutation for the Early Detection of Cholangiocarcinoma.
Shah AA; Alturise F; Alkhalifah T; Faisal A; Khan YD
Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239464
[TBL] [Abstract][Full Text] [Related]
2. An ensemble-based deep learning model for detection of mutation causing cutaneous melanoma.
Ali Shah A; Shaker ASA; Jabbar S; Abbas Q; Al-Balawi TS; Celebi ME
Sci Rep; 2023 Dec; 13(1):22251. PubMed ID: 38097641
[TBL] [Abstract][Full Text] [Related]
3. Deep Learning Approaches for Detection of Breast Adenocarcinoma Causing Carcinogenic Mutations.
Shah AA; Alturise F; Alkhalifah T; Khan YD
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232840
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel bile marker clusterin and a public online prediction platform based on deep learning for cholangiocarcinoma.
Gao L; Lin Y; Yue P; Li S; Zhang Y; Mi N; Bai M; Fu W; Xia Z; Jiang N; Cao J; Yang M; Ma Y; Zhang F; Zhang C; Leung JW; He S; Yuan J; Meng W; Li X
BMC Med; 2023 Aug; 21(1):294. PubMed ID: 37553571
[TBL] [Abstract][Full Text] [Related]
5. A Framework for Prediction of Oncogenomic Progression Aiding Personalized Treatment of Gastric Cancer.
Alotaibi FM; Khan YD
Diagnostics (Basel); 2023 Jul; 13(13):. PubMed ID: 37443684
[TBL] [Abstract][Full Text] [Related]
6. Association between periductal fibrosis and bile duct dilatation among a population at high risk of cholangiocarcinoma: a cross-sectional study of cholangiocarcinoma screening in Northeast Thailand.
Chamadol N; Khuntikeo N; Thinkhamrop B; Thinkhamrop K; Suwannatrai AT; Kelly M; Promthet S
BMJ Open; 2019 Mar; 9(3):e023217. PubMed ID: 30898798
[TBL] [Abstract][Full Text] [Related]
7. [Molecular profiling in daily practice for cholangiocarcinoma].
Selves J
Ann Pathol; 2022 Dec; 42(6S):6S5-6S7. PubMed ID: 36577541
[No Abstract] [Full Text] [Related]
8. Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features.
Liau JY; Tsai JH; Yuan RH; Chang CN; Lee HJ; Jeng YM
Mod Pathol; 2014 Aug; 27(8):1163-73. PubMed ID: 24406866
[TBL] [Abstract][Full Text] [Related]
9. Computer auxiliary diagnosis technique of detecting cholangiocarcinoma based on medical imaging: A review.
Wang S; Liu X; Zhao J; Liu Y; Liu S; Liu Y; Zhao J
Comput Methods Programs Biomed; 2021 Sep; 208():106265. PubMed ID: 34311415
[TBL] [Abstract][Full Text] [Related]
10. Molecular diagnostics and biomarkers in cholangiocarcinoma.
Brown ZJ; Patwardhan S; Bean J; Pawlik TM
Surg Oncol; 2022 Sep; 44():101851. PubMed ID: 36126350
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of deep learning techniques for identification of sarcoma-causing carcinogenic mutations.
Shah AA; Alturise F; Alkhalifah T; Khan YD
Digit Health; 2022; 8():20552076221133703. PubMed ID: 36312852
[TBL] [Abstract][Full Text] [Related]
12. EMLI-ICC: an ensemble machine learning-based integration algorithm for metastasis prediction and risk stratification in intrahepatic cholangiocarcinoma.
Ruan J; Xu S; Chen R; Qu W; Li Q; Ye C; Wu W; Jiang Q; Yan F; Shen E; Chu Q; Jia Y; Zhang X; Fu W; Chen J; Timko MP; Zhao P; Fan L; Shen Y
Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36259363
[TBL] [Abstract][Full Text] [Related]
13. Imaging bile duct tumors: pathologic concepts, classification, and early tumor detection.
Joo I; Lee JM
Abdom Imaging; 2013 Dec; 38(6):1334-50. PubMed ID: 23925840
[TBL] [Abstract][Full Text] [Related]
14. Anatomical, histomorphological and molecular classification of cholangiocarcinoma.
Kendall T; Verheij J; Gaudio E; Evert M; Guido M; Goeppert B; Carpino G
Liver Int; 2019 May; 39 Suppl 1():7-18. PubMed ID: 30882996
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of microRNA-203 in cholangiocarcinoma.
Li J; Gao B; Huang Z; Duan T; Li D; Zhang S; Zhao Y; Liu L; Wang Q; Chen Z; Cheng K
Int J Clin Exp Pathol; 2015; 8(8):9512-6. PubMed ID: 26464713
[TBL] [Abstract][Full Text] [Related]
16. Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile.
Vedeld HM; Grimsrud MM; Andresen K; Pharo HD; von Seth E; Karlsen TH; Honne H; Paulsen V; Färkkilä MA; Bergquist A; Jeanmougin M; Aabakken L; Boberg KM; Folseraas T; Lind GE
Hepatology; 2022 Jan; 75(1):59-73. PubMed ID: 34435693
[TBL] [Abstract][Full Text] [Related]
17. Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assay.
Arnold A; Bahra M; Lenze D; Bradtmöller M; Guse K; Gehlhaar C; Bläker H; Heppner FL; Koch A
Exp Mol Pathol; 2015 Oct; 99(2):344-53. PubMed ID: 26260902
[TBL] [Abstract][Full Text] [Related]
18. Cholangiocarcinoma: new insights into disease pathogenesis and biology.
Braconi C; Patel T
Infect Dis Clin North Am; 2010 Dec; 24(4):871-84, vii. PubMed ID: 20937455
[TBL] [Abstract][Full Text] [Related]
19. Defining the biology of intrahepatic cholangiocarcinoma: molecular pathways and early detection of precursor lesions.
Gibiino G; Fabbri C; Fagiuoli S; Ianiro G; Fornelli A; Cennamo V
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):730-741. PubMed ID: 28272710
[TBL] [Abstract][Full Text] [Related]
20. Cholangiocarcinoma.
Krasinskas AM
Surg Pathol Clin; 2018 Jun; 11(2):403-429. PubMed ID: 29751883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
